64x Bio Launches LV Apex Suite, Expanding Its CellMap-Driven VectorSelect Platform Into Lentiviral Vector Production

SAN FRANCISCO, June 29, 2026--64x Bio Launches LV Apex Suite, Expanding Its CellMap-Driven VectorSelect Platform Into ...
GEN

At BIO, Companies Launch New Products for AAV Manufacturing, AI Drug Discovery

At this year’s BIO International Convention, held June 16–19 in Boston, MA, two companies, 64x Bio and Fauna Bio, introduced new products aimed at improving therapy delivery and identifying novel drug ...
GEN

Asimov Launches Stable AAV Producer Cell Lines for Viral Vector Manufacturing

Asimov launched its AAV Edge Stable Producer system with the goal of addressing the shortcomings of traditional transient transfection-based production and bringing AAV manufacturing standards closer ...
Business Wire

Latus Bio Unveils AAV-Ep+ Capsid Variant Capable of Unprecedented Protein Production in the Brain

PHILADELPHIA--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, has announced new research published today in Science Translational Medicine, ...